Antares pharma announces poster presentation at the pediatric endocrine society 2021 virtual annual meeting

Ewing, n.j., may 03, 2021 (globe newswire) -- antares pharma, inc. (nasdaq: atrs) (“the company”), a specialty pharmaceutical company, today announced that data highlighting the therapeutic potential of subcutaneous testosterone enanthate in younger hypogonadal populations was presented in a poster presentation at the pediatric endocrine society (pes) 2021 virtual annual meeting on april 30 – may 3, 2021.
ATRS Ratings Summary
ATRS Quant Ranking